ChemoCentryx Inc (NASDAQ:CCXI)
| 43.44 BATS BZX Real-Time Price As of 2:30pm ET |  +2.51 / +6.13%Today’s Change | 6.16 Today|||52-Week Range 43.62 | +9.84% Year-to-Date |
Latest CCXI News | Press Releases
No recent news for ChemoCentryx Inc.
Today’s Trading
| Previous close | 40.93 |
| Today’s open | 40.80 |
| Day’s range | 40.40 - 43.62 |
| Volume | 1,115,140 |
| Average volume (3 months) | 990,675 |
| Market cap | $2.2B |
Data as of 2:30pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -306.00% |
| Earnings growth (this year) | -27.36% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -48.03% |
| P/E ratio | NM |
| Price/Sales | 12.68 |
| Price/Book | 131.80 |
Competitors
| ---- | ||
| ARNAArena Pharmaceutical... | +0.68 | +1.46% |
| AIMTAimmune Therapeutics... | -1.92 | -5.25% |
| KRTXKaruna Therapeutics ... | +6.74 | +7.04% |
Data as of 2:30pm ET, 01/17/2020
Financials
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $42.9M |
| Annual profit (last year) | -$38.0M |
| Net profit margin | -88.55% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mountain View, California |
Forecasts
